How Do Patients and Doctors Perceive Medical Services for Rare Diseases Differently in China? Insights from Two National Surveys

Abstract

Background: Increasing attention is being paid to improve the quality of life of patients with rare diseases in China. However, we are currently unaware of the problems encountered in the medical services of rare diseases from the viewpoints of doctors and patients. This study addressed the differences in the perceived barriers of diagnosis and treatments for rare diseases between doctors and patients in China. Methods: Two independent cross-sectional surveys on the perception of Chinese doctors’ and patients’ experiences with rare diseases were launched online between January and February 2018. A non-probability, convenience sampling method was employed to recruit participants. Results: In all, 45 rare diseases were reported by 139 doctors and 1853 patients. Patients with rare diseases faced significantly more difficulties in receiving accurate diagnosis (72.0%) and accessing information related to diagnosis and treatment (77.3%) as compared with doctors (34.5% and 40.3%, p < 0.0001, respectively). Specially, patients felt more difficulties than doctors in obtaining sustainable treatment for rare diseases (84.3% vs. 49.6%, p < 0.001). A higher percentage of patients (58.7%) than that of doctors (39.1%) had concerns in terms of the affordability of drugs. Further, 66.3% patients claimed that the drugs used to treat their conditions were not covered by their current medical insurances, whereas only 21.6% for doctors (p < 0.0001). Moreover, 35.3% of doctors responded that they recommended patients to visit the specialist they knew or were acquainted with, whereas 30.0% of patients said that their doctors chose to treat them based on their past experiences (p < 0.001). Conclusion: The perceived experience of patients with regard to diagnosis and treatment was significantly different from that of doctors. An integrated medical service platform should be established to facilitate better communication and mutual understanding of rare diseases between patients and doctors.

Emotional experience of the diagnostic process of a rare disease and the perception of support systems: A scoping review

“…The need for reciprocal communication to improve opportunities for collaboration and understanding is highlighted (McMullan et al, 2020). The study by Gong et al (2020) shows the differences in perception between doctors and patients, the former treating no more than one or two patients during their career, while the patients instead face the challenges of their illness for life. This element of perception must be overcome.…”

Physicians’ knowledge on specific rare diseases and its associated factors: a national cross-sectional study from China

“…Under this scenario, physicians should support the patient participation in medical encounters by sharing knowledge openly and encouraging patients’ self-reliance. Additionally, patient organizations can play a critical role in providing rare disease patients with services and resources that are not otherwise available through expert patients or invited physicians [ 15 , 21 , 22 ]. Apart from the positive sustainment of patients’ information-seeking process, it is equally important to enhance the pooling of knowledge on rare diseases by the implementation of multidisciplinary and digital platform, and to establish an effective referral method at the healthcare system level.…”

Quality of life and its contributors among adults with late-onset Pompe disease in China

“…The data used for this research were derived from a large, nation-based, cross-sectional survey among people affected by RDs in China in 2018 [ 13 – 15 ]. Since no complete sample frame of patients with RDs exists due to the fact that the epidemiological information of these people is largely unknown in China, a non-probability convenience sampling method was used to recruit participants in collaboration with a variety of national RD patient organizations, namely the Illness Challenge Foundation and its “29 + Alliance” for RD patient organizations, including the China Pompe Care Center (CPCC), the only national Pompe patient organization in China.…”